Bill > S1206

This bill aims to ensure the fair, transparent, and patient-focused use of health technology assessments (HTAs) by the Commonwealth's executive office. Key provisions include: 1. Prohibiting the executive office from relying on HTAs conducted by parties that have received significant funding from insurance companies, pharmaceutical companies, or pharmacy benefit managers within the past 24 months, or HTAs that were not conducted independently. 2. Requiring the executive office to disclose information about HTAs used to support supplemental rebate agreement negotiations, including the identity of the third-party assessor, its funding sources, and the methodologies and data used. 3. Mandating that HTAs used in negotiations must include meaningful input from patients, caregivers, and external experts, and be validated by unrelated third parties. 4. Preventing the executive office from denying Medicaid recipients access to any prescription drug covered under a Medicaid drug rebate agreement based on the results of an HTA. The overall goal is to ensure the use of HTAs is fair, transparent, and patient-focused, while preserving access to necessary prescription drugs for Medicaid beneficiaries.

Health and Social Services

https://malegislature.gov/Bills/191/S1206